Bovilis Cryptium RSSAuthorisedThis medicine is authorised for use in the European Unioncryptosporidium parvum, glycoprotein gp40MedicineVeterinaryAuthorised
Page contentsPage contentsOverviewProduct detailsAuthorisation detailsAssessment historyNews on Bovilis CryptiumMore information on Bovilis CryptiumApplication under evaluationCVMP opinionEuropean Commission decisionOverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information websiteProduct details Name of medicine Bovilis Cryptium Active substance Cryptosporidium parvum, glycoprotein gp40 International non-proprietary name (INN) or common name cryptosporidium parvum, glycoprotein gp40 Pharmacotherapeutic groupImmunologicals for BovidaeInactivated parasitic vaccinesAuthorisation details EMA product number EMEA/V/C/006045 Assessment historyInitial marketing authorisation documentsCVMP summary of positive opinion for Bovilis CryptiumReference Number: EMA/CVMP/416566/2023 English (EN) (132.54 KB - PDF)First published: 06/10/2023ViewNews on Bovilis CryptiumMeeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 October 202306/10/2023More information on Bovilis CryptiumBovilis Cryptium - direct animal healthcare professional communication (DaHPC)This page was last updated on 03/04/2024Share this page